Summary
Stryker Corporation's (SYK) third quarter and year-to-date results for the period ending September 30, 2010, demonstrate robust growth driven by both its Orthopaedic Implants and MedSurg Equipment segments. Net sales saw a significant increase, with the nine-month period up 9% and the third quarter up 7% year-over-year, bolstered by strong domestic performance and continued international expansion, albeit at a slower pace internationally on a reported basis. The company also successfully raised capital through the issuance of senior unsecured notes, strengthening its liquidity position for future growth initiatives, including strategic acquisitions. Profitability also showed substantial improvement, with net earnings for the nine months increasing 22% and the third quarter seeing a remarkable 47% increase. This was driven by improved gross margins, efficient management of selling, general, and administrative expenses, and a favorable operational income increase. The company's strategic focus on new product development is reflected in the increased investment in R&D. Despite ongoing legal and tax matters, the company maintains a strong liquidity position and outlook.
Financial Highlights
52 data points| Revenue | $1.77B |
| Cost of Revenue | $541.00M |
| Gross Profit | $1.23B |
| R&D Expenses | $99.00M |
| SG&A Expenses | $643.00M |
| Operating Expenses | $756.00M |
| Operating Income | $471.00M |
| Net Income | $337.00M |
| EPS (Basic) | $0.85 |
| EPS (Diluted) | $0.85 |
| Shares Outstanding (Basic) | 397.00M |
| Shares Outstanding (Diluted) | 398.00M |
Key Highlights
- 1Net sales increased by 9% for the nine months ended September 30, 2010, reaching $5.32 billion, and by 7% for the third quarter to $1.77 billion.
- 2Net earnings for the nine months increased by 22% to $978.4 million, and by 47% for the third quarter to $337.7 million, demonstrating strong profit growth.
- 3The company successfully issued $1 billion in senior unsecured notes in January 2010, bolstering its cash position for general corporate purposes, including acquisitions.
- 4MedSurg Equipment segment sales showed particularly strong growth, increasing 16% for the nine months and 16% for the third quarter.
- 5Stryker completed two strategic acquisitions in the reporting period: assets related to the Sonopet Ultrasonic Aspirator and Gaymar Industries, enhancing its product offerings.
- 6Significant upcoming event: The company announced a definitive agreement to acquire the Neurovascular division of Boston Scientific Corporation for up to $1.5 billion, signaling aggressive growth strategy.
- 7Despite facing various ongoing legal and tax matters, the company reported effective disclosure controls and procedures and a stable internal control environment.